SCHEMBL3610172

SCHEMBL3610172

Cc1c(C(F)(F)F)nn(C)c1Oc1cc(O[C@@H](C)C(=O)O)c(Cl)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
PTGER4 P35408 1/20 0.39
TSHR P16473 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
PPARG P37231 9/20 0.37
CCR1 P32246 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 1/20 0.33
PKM P14618 1/20 0.33
MAPT P10636 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3599896 0.87 KDM4E (0.40) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3605850 0.87 CYP1A2 (0.38) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3603992 0.86 PTGDR2 (0.37) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3607689 0.86 CCR1 (0.38) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3604317 0.85 KDM4E (0.42) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL3604938 0.85 KDM4E (0.42) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL3606737 0.84 CYP1A2 (0.39) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3606733 0.84 CYP1A2 (0.39) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3606945 0.84 KDM4E (0.39) ALDH1A1KDM4EHSD17B10HPGDPTGER4
SCHEMBL3603323 0.82 PTGER4 (0.34) ALDH1A1KDM4EHSD17B10HPGDPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885KDM4E 2049/4885HSD17B10 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.